Like most websites, we use cookies on the site to provide you with the best experience possible. Click here to see our terms and conditions, or click Agree to hide this notice.


Global Healthcare Partner

Our Mission

Torrent Pharma, with annual revenues of more than Rs 7,900 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 21,500 crores. Torrent Pharma is 4th largest pharma company in India in terms of Enterprise Value. It is ranked 8th in the Indian Pharma Market (IPM) and amongst the Top 5 in therapeutics segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), and Vitamins Minerals Nutritionals (VMN). Torrent Pharma is ranked 5th across chronic/sub-chronic segment in the IPM. 

Torrent has 8 manufacturing facilities (7 in India & 1 in US), of which 5 are USFDA approved along with state-of-the-art R&D infrastructure.  

Torrent Pharma started international acquisitions in 2005 with 90 year old Heumann from Pfizer to enter the German market. Later on purchased ANDA of Minocycline from Ranbaxy for the US Market in 2015. In January 2018, Torrent also acquired Bio-Pharm, Inc. (BPI) a US FDA registered manufacturing facility based in Levittown, USA. 

Today, the Company has presence in over 40 countries and is ranked No. 1 amongst the Indian pharma Companies in Brazil, Germany and Philippines. 

Get in touch

See what else we have to offer


Testimony of this grand, one of a kind event is its absolute top tier global partner organisations. Learn more here.

Meet our speakers

Global leading voices from business, policy, advocacy, government and arts. Explore here.


We thank our sponsors for their support in building a fantastic platform on India’s globalisation.